Skip to main content
logo
Alvotech (ALVO)
NASDAQ: ALVO · Real-Time Price · USD
4.880
+0.150 (3.17%)
Dec 19, 2025, 2:59 PM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
Biosimilar Medicines
489.68M
Log In
Log In
Biosimilar Medicines Growth
435.56%
Log In
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022
Period Ending
Dec '24 Dec '23 Dec '22
United States
273.04M
Log In
Log In
Europe
157.59M
Log In
Log In
Europe Growth
148.13%
Log In
Log In
Rest of World
59.06M
Log In
Log In
North America
-
Log In
Log In
North America Growth
-
Log In
Log In
Asia and Other
-
Log In
Log In
Asia
-
Log In
Log In
Other
-
Log In
Log In